Life360, Inc.·4

Jun 23, 4:40 PM ET

Hulls Chris 4

4 · Life360, Inc. · Filed Jun 23, 2026

Research Summary

AI-generated summary of this filing

Updated

Life360 Director Chris Hulls Exercises Options, Sells Shares

What Happened
Chris Hulls, a director of Life360, exercised 27,000 derivative instruments on June 18, 2026, at an exercise price of $8.19 per share (total cash cost $221,130) and reported a related 27,000-share derivative disposition at $0.00 per share. On the same day he sold 16,042 shares in an open-market transaction at a weighted average price of $47.07, producing proceeds of about $755,097.

Key Details

  • Transaction date: June 18, 2026. Form filed June 23, 2026 (appears filed after the typical 2-business-day Form 4 deadline).
  • Exercise (code M, Acquired): 27,000 shares at $8.19; total reported cash paid $221,130. Footnote F6 indicates the option was fully vested and exercisable.
  • Derivative disposition (code M, Disposed): 27,000 shares reported as disposed at $0.00 per share (no cash consideration reported). See the Form 4 for specifics on the nature of this conversion/disposition.
  • Open-market sale (code S, Disposed): 16,042 shares sold at a weighted average price of $47.07; total proceeds ~$755,097. Footnote F4 notes sales occurred across prices $46.92–$47.39 and that detailed breakdowns are available on request.
  • Sale executed under a pre-established Rule 10b5-1 trading plan adopted Dec 16, 2025 (Footnote F1).
  • Shares owned after the transaction are not specified in the excerpt provided; consult the full Form 4 for total beneficial ownership and CDI/RSU details (see Footnotes F2–F5 for CDI and RSU treatment).

Context

  • The activity shows an option exercise followed by an open-market sale of some shares. Because the sale was made under a Rule 10b5-1 plan, it was pre-established and typically considered routine trading rather than a contemporaneous trading decision.
  • The reported zero-price derivative disposition likely reflects a conversion/settlement mechanism; the Form 4 footnotes should be consulted for precise mechanics.
  • Purchases/exercises can be more informative than sales as a bullish signal, but here the sale portion generated significant proceeds (~$755k) and was pre-planned.

Insider Transaction Report

Form 4
Period: 2026-06-18
Hulls Chris
Director
Transactions
  • Exercise/Conversion

    Common Stock

    [F1][F2][F3]
    2026-06-18$8.19/sh+27,000$221,130422,941 total
  • Sale

    Common Stock

    [F1][F4][F2][F3]
    2026-06-18$47.07/sh16,042$755,097406,899 total
  • Exercise/Conversion

    Stock Option (right to buy)

    [F1][F6]
    2026-06-1827,000125,801 total
    Exercise: $8.19Exp: 2028-05-20Common stock (27,000 underlying)
Holdings
  • Common Stock

    [F5]
    (indirect: By Trust)
    195,312
  • Common Stock

    [F5]
    (indirect: By Trust)
    195,312
  • Common Stock

    [F5]
    (indirect: By Trust)
    195,312
Footnotes (6)
  • [F1]The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
  • [F2]Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.
  • [F3]Includes 134,496 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  • [F4]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $46.92 to $47.39, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  • [F5]Represents shares of the Issuer's common stock underlying 585,938 CDIs.
  • [F6]The stock option is fully vested and exercisable.
Signature
/s/ Jay Sood, Attorney-in-Fact|2026-06-23

Documents

1 file
  • 4
    wk-form4_1782247197.xmlPrimary

    FORM 4